1.1 Articolo in rivista

1.1 Articolo in rivista: [36182] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 12.001 a 12.020 di 36.182

Antibiotic-induced Dysbiosis as a Putative Actionable Driver of Cancer Immunity in Renal Cell Carcinoma

2020-01-01 Pinato, D. J.

Perspectives on the neoadjuvant use of immunotherapy in hepatocellular carcinoma

2020-01-01 Pinato, David J; Fessas, Petros; Sapisochin, Gonzalo; Marron, Thomas U

Shifting paradigms in the systemic management of hepatocellular carcinoma

2020-01-01 Pinato, D. J.

Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

2019-01-01 Flynn, M. J.; Sayed, A. A.; Sharma, R.; Siddique, A.; Pinato, D. J.

Therapeutic hierarchy in hepatocellular carcinoma: A dispute of evidence versus practice

2019-01-01 Pinato, D. J.

Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis

2019-01-01 Lachowski, D.; Cortes, E.; Rice, A.; Pinato, D.; Rombouts, K.; del Rio Hernandez, A.

Influence of HIV infection on the natural history of hepatocellular carcinoma: Results from a global multicohort study

2019-01-01 Pinato, D. J.; Allara, E.; Chen, T. -Y.; Trevisani, F.; Minguez, B.; Zoli, M.; Harris, M.; Pria, A. D.; Merchante, N.; Platt, H.; Jain, M.; Caturelli, E.; Kikuchi, L.; Pineda, J.; Nelson, M.; Farinati, F.; Rapaccini, G. L.; Aytaman, A.; Yin, M.; Tan, C. -K.; Bower, M.; Giannini, E. G.; Brau, N.

The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma

2019-01-01 Sanghera, C.; Teh, J. J.; Pinato, D. J.

Antibiotic therapy and outcome from immune-checkpoint inhibitors

2019-01-01 Pinato, D. J.; Gramenitskaya, D.; Altmann, D. M.; Boyton, R. J.; Mullish, B. H.; Marchesi, J. R.; Bower, M.

Recent advances in hiv-associated kaposi sarcoma

2019-01-01 Pria, A. D.; Pinato, D. J.; Bracchi, M.; Bower, M.

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma

2019-01-01 Pinato, D. J.; Brown, M. W.; Trousil, S.; Aboagye, E. O.; Beaumont, J.; Zhang, H.; Coley, H. M.; Mauri, F. A.; Sharma, R.

Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer

2019-01-01 Pinato, D. J.; Howlett, S.; Ottaviani, D.; Urus, H.; Patel, A.; Mineo, T.; Brock, C.; Power, D.; Hatcher, O.; Falconer, A.; Ingle, M.; Brown, A.; Gujral, D.; Partridge, S.; Sarwar, N.; Gonzalez, M.; Bendle, M.; Lewanski, C.; Newsom-Davis, T.; Allara, E.; Bower, M.

Retinoic Acid Receptor-β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin-Driven Activation and Durotaxis in Hepatic Stellate Cells

2019-01-01 Cortes, E.; Lachowski, D.; Rice, A.; Chronopoulos, A.; Robinson, B.; Thorpe, S.; Lee, D. A.; Possamai, L. A.; Wang, H.; Pinato, D. J.; del Rio Hernandez, A. E.

Is justice delayed justice denied? An empirical approach

2021-01-01 Melcarne, A.; Ramello, G. B.; Spruk, R.

PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity

2019-01-01 Black, J. R.; Goldin, R. D.; Foxton, M.; Marafioti, T.; Akarca, A. U.; Pria, A. D.; Brock, C.; Bower, M.; Pinato, D. J.

Breaking Kuhn's paradigm in advanced hepatocellular carcinoma

2018-01-01 Pinato, D. J.

Partnership and innovation in the pharmaceutical industry: the case of clinical research

2021-01-01 Ippoliti, R.; Ramello, G. B.; Scherer, F. M.

The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma

2018-01-01 Pinato, D. J.; Sharma, R.; Citti, C.; Platt, H.; Ventura-Cots, M.; Allara, E.; Chen, T. -Y.; Dalla Pria, A.; Jain, M.; Minguez, B.; Kikuchi, L.; Kaufman West, E.; Merli, M.; Kaplan, D. E.; Hasson, H.; Marks, K.; Nelson, M.; Nunez, M.; Aytaman, A.; Bower, M.; Brau, N.

Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma

2018-01-01 Ul-Haq, I.; Dalla Pria, A.; Suardi, E.; Pinato, D. J.; Froeling, F.; Forni, J.; Randell, P.; Bower, M.

Editorial: a step forward in refining prognostication for patients with HIV-associated hepatocellular carcinoma—Authors’ reply

2018-01-01 Pinato, D. J.; Brau, N.; Bower, M.

Titolo	Data di pubblicazione	Autore(i)
Antibiotic-induced Dysbiosis as a Putative Actionable Driver of Cancer Immunity in Renal Cell Carcinoma	*1-gen-2020*	Pinato, D. J.
Perspectives on the neoadjuvant use of immunotherapy in hepatocellular carcinoma	*1-gen-2020*	Pinato, David J; Fessas, Petros; Sapisochin, Gonzalo; Marron, Thomas U
Shifting paradigms in the systemic management of hepatocellular carcinoma	*1-gen-2020*	Pinato, D. J.
Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma	*1-gen-2019*	Flynn, M. J.; Sayed, A. A.; Sharma, R.; Siddique, A.; Pinato, D. J.
Therapeutic hierarchy in hepatocellular carcinoma: A dispute of evidence versus practice	*1-gen-2019*	Pinato, D. J.
Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis	*1-gen-2019*	Lachowski, D.; Cortes, E.; Rice, A.; Pinato, D.; Rombouts, K.; del Rio Hernandez, A.
Influence of HIV infection on the natural history of hepatocellular carcinoma: Results from a global multicohort study	*1-gen-2019*	Pinato, D. J.; Allara, E.; Chen, T. -Y.; Trevisani, F.; Minguez, B.; Zoli, M.; Harris, M.; Pria, A. D.; Merchante, N.; Platt, H.; Jain, M.; Caturelli, E.; Kikuchi, L.; Pineda, J.; Nelson, M.; Farinati, F.; Rapaccini, G. L.; Aytaman, A.; Yin, M.; Tan, C. -K.; Bower, M.; Giannini, E. G.; Brau, N.
The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma	*1-gen-2019*	Sanghera, C.; Teh, J. J.; Pinato, D. J.
Antibiotic therapy and outcome from immune-checkpoint inhibitors	*1-gen-2019*	Pinato, D. J.; Gramenitskaya, D.; Altmann, D. M.; Boyton, R. J.; Mullish, B. H.; Marchesi, J. R.; Bower, M.
Recent advances in hiv-associated kaposi sarcoma	*1-gen-2019*	Pria, A. D.; Pinato, D. J.; Bracchi, M.; Bower, M.
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma	*1-gen-2019*	Pinato, D. J.; Brown, M. W.; Trousil, S.; Aboagye, E. O.; Beaumont, J.; Zhang, H.; Coley, H. M.; Mauri, F. A.; Sharma, R.
Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer	*1-gen-2019*	Pinato, D. J.; Howlett, S.; Ottaviani, D.; Urus, H.; Patel, A.; Mineo, T.; Brock, C.; Power, D.; Hatcher, O.; Falconer, A.; Ingle, M.; Brown, A.; Gujral, D.; Partridge, S.; Sarwar, N.; Gonzalez, M.; Bendle, M.; Lewanski, C.; Newsom-Davis, T.; Allara, E.; Bower, M.
Retinoic Acid Receptor-β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin-Driven Activation and Durotaxis in Hepatic Stellate Cells	*1-gen-2019*	Cortes, E.; Lachowski, D.; Rice, A.; Chronopoulos, A.; Robinson, B.; Thorpe, S.; Lee, D. A.; Possamai, L. A.; Wang, H.; Pinato, D. J.; del Rio Hernandez, A. E.
Is justice delayed justice denied? An empirical approach	*1-gen-2021*	Melcarne, A.; Ramello, G. B.; Spruk, R.
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity	*1-gen-2019*	Black, J. R.; Goldin, R. D.; Foxton, M.; Marafioti, T.; Akarca, A. U.; Pria, A. D.; Brock, C.; Bower, M.; Pinato, D. J.
Breaking Kuhn's paradigm in advanced hepatocellular carcinoma	*1-gen-2018*	Pinato, D. J.
Partnership and innovation in the pharmaceutical industry: the case of clinical research	*1-gen-2021*	Ippoliti, R.; Ramello, G. B.; Scherer, F. M.
The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma	*1-gen-2018*	Pinato, D. J.; Sharma, R.; Citti, C.; Platt, H.; Ventura-Cots, M.; Allara, E.; Chen, T. -Y.; Dalla Pria, A.; Jain, M.; Minguez, B.; Kikuchi, L.; Kaufman West, E.; Merli, M.; Kaplan, D. E.; Hasson, H.; Marks, K.; Nelson, M.; Nunez, M.; Aytaman, A.; Bower, M.; Brau, N.
Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma	*1-gen-2018*	Ul-Haq, I.; Dalla Pria, A.; Suardi, E.; Pinato, D. J.; Froeling, F.; Forni, J.; Randell, P.; Bower, M.
Editorial: a step forward in refining prognostication for patients with HIV-associated hepatocellular carcinoma—Authors’ reply	*1-gen-2018*	Pinato, D. J.; Brau, N.; Bower, M.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 12.001 a 12.020 di 36.182

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext21435
reserved7318
open4977
restricted2336
partially open90
embargoed17
mixed9